These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 37060825)
41. MicroRNA and LncRNA Expression Profiles in Human Estrogen Receptor Positive Breast Cancer. Shao X; Huang P; Shi L; Lei L; Cao W; Chen Z; Wang X; Zheng Y Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775882 [TBL] [Abstract][Full Text] [Related]
42. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Lowery AJ; Miller N; Devaney A; McNeill RE; Davoren PA; Lemetre C; Benes V; Schmidt S; Blake J; Ball G; Kerin MJ Breast Cancer Res; 2009; 11(3):R27. PubMed ID: 19432961 [TBL] [Abstract][Full Text] [Related]
43. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4. Yang X; Sun L; Wang L; Yao B; Mo H; Yang W Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291 [TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNA SNHG7 promotes neuroblastoma progression through sponging miR-323a-5p and miR-342-5p. Jia J; Zhang D; Zhang J; Yang L; Zhao G; Yang H; Wang J Biomed Pharmacother; 2020 Aug; 128():110293. PubMed ID: 32534305 [TBL] [Abstract][Full Text] [Related]
45. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches. Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149 [TBL] [Abstract][Full Text] [Related]
46. METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1/c-Myc axis. Liu J; Yuan JF; Wang YZ Exp Cell Res; 2022 Jul; 416(1):113149. PubMed ID: 35405116 [TBL] [Abstract][Full Text] [Related]
47. miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer. She K; Yan H; Huang J; Zhou H; He J Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29131440 [TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer. Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685 [TBL] [Abstract][Full Text] [Related]
49. LncRNA SNHG7 participates in osteosarcoma progression by down-regulating p53 via binding to DNMT1. Zhang GD; Gai PZ; Liao GY; Li Y Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3602-3610. PubMed ID: 31114984 [TBL] [Abstract][Full Text] [Related]
50. Opposite trends of GAS6 and GAS6-AS expressions in breast cancer tissues. Lavasani A; Hussen BM; Taheri F; Sattari A; Yousefi H; Omrani MD; Nazer N; Ghafouri-Fard S; Taheri M Exp Mol Pathol; 2021 Feb; 118():104600. PubMed ID: 33359886 [TBL] [Abstract][Full Text] [Related]
51. Knockdown of LncRNA SNHG7 inhibited epithelial-mesenchymal transition in prostate cancer though miR-324-3p/WNT2B axis in vitro. Han Y; Hu H; Zhou J Pathol Res Pract; 2019 Oct; 215(10):152537. PubMed ID: 31324390 [TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA SNHG7 promotes malignant melanoma progression through negative modulation of miR-9. Wang W; Liu G; Liu M; Li X Histol Histopathol; 2020 Sep; 35(9):973-981. PubMed ID: 32365219 [TBL] [Abstract][Full Text] [Related]
53. Genome-wide study of ER-regulated lncRNAs shows AP000439.3 may function as a key regulator of cell cycle in breast cancer. Zhang Y; Wang DL; Yan HY; Liao JY; He JH; Hu KS; Deng WX; Wang YJ; Xing HT; Koeffler HP; Yin D Oncol Rep; 2017 Nov; 38(5):3227-3237. PubMed ID: 29048636 [TBL] [Abstract][Full Text] [Related]
54. Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer. Ghafouri-Fard S; Taherian-Esfahani Z; Dashti S; Kholghi Oskooei V; Taheri M; Samsami M Exp Mol Pathol; 2020 Jun; 114():104415. PubMed ID: 32165090 [TBL] [Abstract][Full Text] [Related]
55. Role of SNHG7-miR-653-5p-STAT2 feedback loop in regulating neuroblastoma progression. Chi R; Chen X; Liu M; Zhang H; Li F; Fan X; Wang W; Lu H J Cell Physiol; 2019 Aug; 234(8):13403-13412. PubMed ID: 30623419 [TBL] [Abstract][Full Text] [Related]
56. Long non‑coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4. Xiong X; Feng Y; Li L; Yao J; Zhou M; Zhao P; Huang F; Zeng L; Yuan L Oncol Rep; 2020 May; 43(5):1503-1515. PubMed ID: 32323846 [TBL] [Abstract][Full Text] [Related]
57. The natural antisense transcript HAS2-AS1 regulates breast cancer cells aggressiveness independently from hyaluronan metabolism. Parnigoni A; Caon I; Teo WX; Hua SH; Moretto P; Bartolini B; Viola M; Karousou E; Yip GW; Götte M; Heldin P; Passi A; Vigetti D Matrix Biol; 2022 May; 109():140-161. PubMed ID: 35395387 [TBL] [Abstract][Full Text] [Related]
58. Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells. Li Y; Jiang B; Wu X; Huang Q; Chen W; Zhu H; Qu X; Xie L; Ma X; Huang G Biochem Biophys Res Commun; 2018 Sep; 503(1):45-50. PubMed ID: 29792859 [TBL] [Abstract][Full Text] [Related]
59. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer. Fan CN; Ma L; Liu N J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490 [TBL] [Abstract][Full Text] [Related]
60. Identification of oxytocin-related lncRNAs and assessment of their expression in breast cancer. Behtaji S; Ghafouri-Fard S; Sayad A; Sattari A; Rederstorff M; Taheri M Sci Rep; 2021 Mar; 11(1):6471. PubMed ID: 33742056 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]